Dubai Telegraph - Who should get paid for nature's sequenced genes?

EUR -
AED 3.973379
AFN 72.895147
ALL 98.366008
AMD 417.753709
ANG 1.945655
AOA 986.036662
ARS 1068.514566
AUD 1.650375
AWG 1.947188
AZN 1.834097
BAM 1.955115
BBD 2.179757
BDT 129.004824
BGN 1.955902
BHD 0.407657
BIF 3137.730221
BMD 1.081771
BND 1.430912
BOB 7.459388
BRL 6.232624
BSD 1.079532
BTN 90.746222
BWP 14.491193
BYN 3.532963
BYR 21202.715136
BZD 2.176058
CAD 1.505663
CDF 3147.954225
CHF 0.938496
CLF 0.036952
CLP 1019.622369
CNY 7.717787
CNH 7.701448
COP 4718.696707
CRC 554.203365
CUC 1.081771
CUP 28.666936
CVE 110.2264
CZK 25.353448
DJF 192.244456
DKK 7.460457
DOP 65.018133
DZD 144.280824
EGP 52.693057
ERN 16.226568
ETB 129.004017
FJD 2.467087
FKP 0.827738
GBP 0.831844
GEL 2.953406
GGP 0.827738
GHS 17.542857
GIP 0.827738
GMD 75.197369
GNF 9310.825563
GTQ 8.345078
GYD 225.860907
HKD 8.405979
HNL 27.232715
HRK 7.452354
HTG 142.271494
HUF 405.49973
IDR 17015.07072
ILS 4.027099
IMP 0.827738
INR 90.943908
IQD 1414.217836
IRR 45547.975558
ISK 148.506141
JEP 0.827738
JMD 170.789403
JOD 0.766868
JPY 165.880412
KES 139.256112
KGS 92.813667
KHR 4388.503781
KMF 492.692348
KPW 973.593818
KRW 1496.11145
KWD 0.331736
KYD 0.899693
KZT 529.209571
LAK 23666.712282
LBP 96727.427546
LKR 317.028981
LRD 207.281246
LSL 19.121181
LTL 3.194189
LVL 0.654353
LYD 5.211223
MAD 10.650071
MDL 19.351134
MGA 4990.344721
MKD 61.593431
MMK 3513.550597
MNT 3675.858501
MOP 8.638975
MRU 42.685052
MUR 49.998851
MVR 16.615803
MWK 1871.979071
MXN 21.704766
MYR 4.750014
MZN 69.136425
NAD 19.121181
NGN 1775.802871
NIO 39.726456
NOK 11.853529
NPR 145.195497
NZD 1.813757
OMR 0.416497
PAB 1.079522
PEN 4.063415
PGK 4.323526
PHP 63.0878
PKR 299.845585
PLN 4.340175
PYG 8594.069934
QAR 3.936022
RON 4.974635
RSD 117.06915
RUB 105.472215
RWF 1468.17908
SAR 4.062528
SBD 9.014985
SCR 14.858132
SDG 650.694392
SEK 11.505015
SGD 1.433109
SHP 0.827738
SLE 24.546105
SLL 22684.197308
SOS 616.981091
SRD 37.135059
STD 22390.479347
SVC 9.44578
SYP 2717.982834
SZL 19.126391
THB 36.488278
TJS 11.497174
TMT 3.786199
TND 3.343929
TOP 2.533619
TRY 37.092885
TTD 7.316438
TWD 34.675112
TZS 2947.826672
UAH 44.651689
UGX 3956.614455
USD 1.081771
UYU 44.924268
UZS 13802.166694
VEF 3918772.931288
VES 45.62094
VND 27406.672856
VUV 128.43008
WST 3.03024
XAF 655.724345
XAG 0.03207
XAU 0.000397
XCD 2.923541
XDR 0.811431
XOF 655.733434
XPF 119.331742
YER 270.794409
ZAR 19.107703
ZMK 9737.239573
ZMW 28.7432
ZWL 348.329879
  • RBGPF

    62.3500

    62.35

    +100%

  • SCS

    -0.3800

    12.21

    -3.11%

  • BCC

    -6.9800

    131.64

    -5.3%

  • NGG

    -0.8800

    65.12

    -1.35%

  • RYCEF

    0.0400

    7.25

    +0.55%

  • CMSC

    -0.1600

    24.57

    -0.65%

  • BCE

    -0.2300

    32.46

    -0.71%

  • RIO

    0.4000

    66.58

    +0.6%

  • GSK

    0.2900

    38.17

    +0.76%

  • CMSD

    -0.0400

    24.84

    -0.16%

  • RELX

    -0.2500

    47.91

    -0.52%

  • JRI

    -0.0900

    12.98

    -0.69%

  • AZN

    -0.7900

    75.22

    -1.05%

  • VOD

    -0.2600

    9.28

    -2.8%

  • BTI

    -0.4500

    34.46

    -1.31%

  • BP

    -1.6900

    29.36

    -5.76%

Who should get paid for nature's sequenced genes?
Who should get paid for nature's sequenced genes? / Photo: Menahem KAHANA - AFP/File

Who should get paid for nature's sequenced genes?

Much of the vanilla that flavors our ice cream today is artificial, derived from the genetic signature of a plant that hundreds of years ago was known only to an Indigenous Mexican tribe.

Text size:

The plant's sequenced genomic information, available on public databases, was used as the basis for a synthetic flavoring that today competes with vanilla grown in several countries, mainly by small-scale farmers.

Few, if any, benefits of the lucrative scientific advance have trickled down to the communities that gave us vanilla in the first place.

"Wild genetic resources and pharmaceuticals ... are a multi-multi-billion dollar businesses. They clearly are profitable... that's not in dispute," Charles Barber of the World Resources Institute think tank told AFP.

"A great deal of really valuable information has fed into the system from research and utilization of wild genetic resources. And there is no mechanism currently to compensate the people where this information is coming from" in the form of digitally sequenced data, he added.

Much of the information comes from poor countries.

Fair sharing of the gains derived from digitally-stored genetic sequencing data has been a headache for negotiators at the COP16 biodiversity summit into its second week in Cali, Colombia.

At the last conference, in Montreal in 2022, 196 country parties to the UN's Convention on Biological Diversity (CBD) agreed to create a benefit-sharing mechanism for the use of digital sequence information (DSI).

Two years later, they still need to resolve such basic questions as who pays, how much, into which fund, and to whom does the money go?

- 'Cheap and very fast' -

The issue is a complex one.

There is little debate that genetic data-sharing on mostly free-access platforms is crucial for human advancement through medicine and vaccine development, for example.

But how to quantify the value of the sequenced information itself? And should the first people to discover a plant's particular usefulness be compensated?

"Sequencing technology has become so advanced that you can go with a... handheld device a little bit bigger than a cell phone and you can literally sequence a genome in an hour or two and upload it as you sequence it," Pierre du Plessis, a DSI expert and former negotiator for African countries at the CBD told AFP.

These gene sequences are then uploaded to databases which artificial intelligence can mine for potential leads for product development.

DSI is worth an estimated hundreds of billions of dollars a year. And there is a lot of it out there.

"Once the sequence is put into a public database, generally, no benefit-sharing obligations apply," Nithin Ramakrishnan, a researcher with the Third World Network, an advocacy NGO for developing countries, told AFP in Cali.

"Like when the sandalwood sequence information is available in the database whether India wants to share its sandalwood... with a cosmetic company or not, doesn't matter.

- Mandatory -

A point of contention in Cali is a demand from developing countries that payment for DSI use be mandatory, perhaps through a one-percent levy on profits from drugs, cosmetics or other products.

They also want guarantees of non-monetary benefits such as access to vaccines produced from genetic information sequenced from viruses and other pathogens.

"We want real understanding, sector-specific understanding of what non-monetary benefits will be shared and we want the system to be obligatory -- the users should have some form of obligation to share benefits," said Ramakrishnan.

Another sticking point is access for Indigenous people and local communities to DSI funds.

Developing countries want the information on genetic databases to be traceable and "answerable to governments" of the countries where it comes from, said Ramakrishnan.

But rich nations and many researchers oppose such a model which they fear will be too onerous, potentially putting the brakes on scientific pursuits that could benefit all humankind.

With such divergent points of view, observers are doubtful the Cali COP will emerge with any firm decisions on the outstanding questions by closing time on Friday.

The World Wildlife Fund has said "many more rounds of negotiations appear necessary" on DSI.

Added Barber: "I think it's not going to all get solved here."

Y.Sharma--DT